Found 19 matching trials
A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)
PHASE1The phase I/II clinical study is to investigate the safety, tolerability an...
Location
Anhui Province Cancer Hospital
A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL
PHASE2The phase II clinical study is to investigate the safety, tolerability, eff...
Location
Beijing Cancer Hospital
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma
PHASE3The purpose of this study is to evaluate the safety and efficacy of orelabr...
Location
The first affiliated hospital of bengbu medical college
Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
PHASE2This study is a multi-center, open-label, single-arm, non-randomized phase ...
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
A Study to Evaluate ICP-022 in Patients With CLL/ SLL
PHASE1The phase I/II clinical study is to investigate the safety, tolerability an...
Location
Anhui Province Cancer Hospital
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
PHASE1The purpose of the study is to assess the Safety, Tolerability, PK/PD and p...
Location
The First Affiliated Hospital of Bengbu Medical College
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
N/ATo evaluate the safety and effecacy of Orelabrutinib therapy in patients wi...
Location
Deparment of Hematology, Peking University People's Hospital
A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies
PHASE1This is a Phase I/II, multicenter, open-label study to evaluate the safety,...
Status
Active Not Recruiting
Location
Mayo Clinic-Mayo Clinic Hospital-Phoenix
A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
PHASE2The phase II clinical study is to investigate the safety, tolerability, eff...
Location
Anhui Provincial Hospital
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma
PHASE2This is a phase II, prospective clinical study to evaluate the efficacy and...
Status
Active Not Recruiting
Location
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China